Takeda Pharmaceuticals U.S.A. and Affymax, Inc. Company Profile
Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Development Center Americas, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology, gastroenterology and cardiovascular disease treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabetes, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit www.tpna.com.
News Articles
Omontys Recalled: Affymax, Takeda Looking for Root Cause
On Sunday, February 24, Omontys (peginesatide), which was approved in March 2012 by the U.S. Food and Drug Administration (FDA), was voluntarily recalled by Affymax and Takeda due to reports of fatali...
Takeda and Affymax Announce Supply Agreement for Omontys (Peginesatide) Injection with DSI Renal
DEERFIELD, Ill. & PALO ALTO, Calif.--(BUSINESS WIRE)--Jan 7, 2013 - Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) and Affymax, Inc. (Nasdaq: AFFY) today announced that Takeda Pharmaceuticals America...
DEERFIELD, Ill. & PALO ALTO, Calif.--(BUSINESS WIRE)--Jul 12, 2012 - Takeda Pharmaceuticals U.S.A. (TPUSA) and Affymax, Inc. (Nasdaq:AFFY) today announced that Takeda Pharmaceuticals America, Inc....
Affymax, Takeda Recall Omontys Due to Reactions, Deaths
PALO ALTO, Calif.— Affymax Inc. and Takeda Pharmaceuticals are voluntarily recalling all lots of the anemia drug Omontys after reports of fatalities and anaphylaxis, a life-threatening allergic reac...
Takeda, Affymax Announce Supply Agreement for Omontys with DSI Renal
DEERFIELD, Ill. & PALO ALTO, Calif.—Takeda Pharmaceuticals U.S.A. and Affymax announced that Takeda Pharmaceuticals America has entered into a supply agreement for sourcing and supply of Omontys...
Affymax, Takeda recall anemia drug Omontys after deaths
TOKYO (Reuters) - U.S. Affymax Inc. and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anemia treatment Omontys (peginesatide) in the U.S., due to reports of serious...
Affymax, Takeda recall anaemia drug Omontys after deaths
TOKYO, Feb 24 (Reuters) - U.S. Affymax Inc. and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anaemia treatment Omontys (peginesatide) in the U.S., due to reports of...
AUDIENCE: Patients, Healthcare Professionals, Hematology ISSUE: Affymax, Inc. and Takeda Pharmaceutical Company Limited along with the U.S. Food and Drug Administration (FDA) are informing the public...
Drugs and Medications
Prevacid [Novartis Consumer Health, Inc.]
PREVACID 24 HRLansoprazole delayed-release capsules 15mg / acid reducer
Lupron depot ped [Takeda Pharmaceutical Company LTD]
LUPRON DEPOT-PED (leuprolide acetate for depot suspension) 7.5 mg, 11.25 mg and 15 mg
Edarbi [Takeda Pharmaceuticals America, Inc.]
These HIGHLIGHTS do not include all the information needed to use EDARBI safely and effectively. See full prescribing information for EDARBI. Edarbi (azilsartan medoxomil) tabletsInitial U.S. Approval...
Actos [Takeda Pharmaceutical Co LTD]
ACTOS (pioglitazone hydrochloride) Tablets
Actos [Rebel Distributors Corp.]
ACTOS (pioglitazone hydrochloride) Tablets
PubMed Articles
Pioglitazone and risk of bladder cancer: clarification of the design of the French study.
Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
Since the 1990's, cheating athletes have abused substances to increase their oxygen transport capabilities; among these substances, recombinant EPO is the most well known. Currently, other investigati...
Long-term response to maintenance treatment with rituximab in CD20(+) multiple myeloma.
Structure-based discovery of cellular-active allosteric inhibitors of FAK.
In order to develop potent and selective focal adhesion kinase (FAK) inhibitors, synthetic studies on pyrazolo[4,3-c][2,1]benzothiazines targeted for the FAK allosteric site were carried out. Based on...
Numerous aggregates of "tiny" micromegakaryocytes in the bone marrow.
Clinical Trials
Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg
The objective of this study was to investigate the bioequivalence of Mylan pioglitazone HCl 45 mg tablets to Takeda Actos® 45 mg tablets following a single, oral 45 mg (1 x 45 mg) dose ad...
Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg
The objective of this study was to investigate the bioequivalence of Mylan pioglitazone HCl 45 mg tablets to Takeda Actos® 45 mg tablets following a single, oral 45 mg (1 x 45 mg) dose ad...
Companies
Affymax, Inc. & Takeda Pharmaceutical Company Limited
Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of p...
Affymax, Inc. and Takeda Pharmaceuticals U.S.A., Inc.
Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of p...
Takeda Pharmaceuticals U.S.A., Inc. and Affymax, Inc.
Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the...
Takeda Pharmaceuticals U.S.A. and Affymax, Inc.
Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Development Center Americas, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest p...
Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. For additional informat...
More Information about "Takeda Pharmaceuticals U.S.A. and Affymax, Inc." on BioPortfolio
We have published hundreds of Takeda Pharmaceuticals U.S.A. and Affymax, Inc. news stories on BioPortfolio along with dozens of Takeda Pharmaceuticals U.S.A. and Affymax, Inc. Clinical Trials and PubMed Articles about Takeda Pharmaceuticals U.S.A. and Affymax, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda Pharmaceuticals U.S.A. and Affymax, Inc. Companies in our database. You can also find out about relevant Takeda Pharmaceuticals U.S.A. and Affymax, Inc. Drugs and Medications on this site too.
